Goal of the treatment for sarcoidosis - Minimize harm for the patient

被引:8
作者
Hunninghake, GW [1 ]
机构
[1] VET AFFAIRS MED CTR, IOWA CITY, IA 52242 USA
关键词
D O I
10.1164/ajrccm.156.5.ed17-97
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
引用
收藏
页码:1369 / 1370
页数:2
相关论文
共 9 条
[1]   OUTCOME OF THE TREATMENT FOR SARCOIDOSIS [J].
HUNNINGHAKE, CW ;
GILBERT, S ;
PUERINGER, R ;
DAYTON, C ;
FLOERCHINGER, C ;
HELMERS, R ;
MERCHANT, R ;
WILSON, J ;
GALVIN, J ;
SCHWARTZ, D .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 149 (04) :893-898
[2]  
HUNNINGHAKE GW, 1983, AM REV RESPIR DIS, V128, P634
[3]   PULMONARY SARCOIDOSIS - A DISORDER MEDIATED BY EXCESS HELPER LYMPHOCYTE-T ACTIVITY AT SITES OF DISEASE-ACTIVITY [J].
HUNNINGHAKE, GW ;
CRYSTAL, RG .
NEW ENGLAND JOURNAL OF MEDICINE, 1981, 305 (08) :429-434
[4]   THE USE OF LOW-DOSE METHOTREXATE IN REFRACTORY SARCOIDOSIS [J].
LOWER, EE ;
BAUGHMAN, RP .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1990, 299 (03) :153-157
[5]   EVALUATION OF THE INVITRO AND INVIVO EFFECTS OF CYCLOSPORINE ON THE LUNG LYMPHOCYTE-T ALVEOLITIS OF ACTIVE PULMONARY SARCOIDOSIS [J].
MARTINET, Y ;
PINKSTON, P ;
SALTINI, C ;
SPURZEM, J ;
MULLERQUERNHEIM, J ;
CRYSTAL, RG .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1988, 138 (05) :1242-1248
[6]   INTERFERON AND GROWTH-FACTOR ACTIVITY FOR HUMAN-LUNG FIBROBLASTS - RELEASE FROM BRONCHOALVEOLAR CELLS FROM PATIENTS WITH ACTIVE SARCOIDOSIS [J].
MOSELEY, PL ;
HEMKEN, C ;
MONICK, M ;
NUGENT, K ;
HUNNINGHAKE, GW .
CHEST, 1986, 89 (05) :657-662
[7]   SPONTANEOUS RELEASE OF INTERLEUKIN-2 BY LUNG LYMPHOCYTES-T IN ACTIVE PULMONARY SARCOIDOSIS [J].
PINKSTON, P ;
BITTERMAN, PB ;
CRYSTAL, RG .
NEW ENGLAND JOURNAL OF MEDICINE, 1983, 308 (14) :793-800
[8]  
THOMAS PD, 1987, AM REV RESPIR DIS, V135, P747
[9]   Treatment of progressive pulmonary sarcoidosis with cyclosporin A - A randomized controlled trial [J].
Wyser, CP ;
vanSchalkwyk, EM ;
Alheit, B ;
Bardin, PG ;
Joubert, JR .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1997, 156 (05) :1371-1376